查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1700026

2032 年細胞培養基市場預測：按產品類型、細胞類型、配方類型、應用、最終用戶和地區進行的全球分析

Cell Culture Media Market Forecasts to 2032 - Global Analysis By Product Type, Cell Type, Formulation Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球細胞培養基市場預計在 2025 年達到 66 億美元，到 2032 年將達到 152.5 億美元，預測期內的複合年成長率為 12.7%。

細胞培養基是富含營養的溶液，用於在實驗室條件下支持細胞的生長、維持和增殖。培養基提供細胞在自然環境之外生長所需的必需營養素、維生素、胺基酸、鹽和生長因子。根據細胞類型及其預期用途，培養基可以是化學定義的、基於血清的或無血清的。在試管內中檢查和操作細胞的能力使得這些培養基在藥物發現、再生醫學、癌症研究和生物製藥製造等多個領域中至關重要。

根據世界衛生組織估計，2021年全球將有128,000例麻疹病例和死亡病例，其中大多數是未接種疫苗或疫苗接種不足的五歲以下兒童。

生物製藥需求不斷成長

慢性病的增加和全球人口老化推動了對先進生物製藥的需求不斷成長。生物製藥的生產需要高品質的細胞培養基，使得這個市場變得越來越重要。人們對生技藥品和生物相似藥的日益關注進一步推動了對高效細胞培養基的需求。此外，幹細胞和再生醫學等基於細胞的研究的增加正在加速市場成長。隨著製藥公司對研發的大力投入，細胞培養基市場正在穩步成長。

媒體發展的複雜性

細胞培養基開發是一個具有挑戰性的過程，需要針對特定細胞株和應用客製化的複雜配方。研究、測試和開發客製化媒體的高成本可能會成為小型製造商的障礙。此外，對細胞培養產品的嚴格監管要求進一步增加了複雜性和成本。原料的多變性和性能的不一致性給媒體開發商帶來了額外的障礙。當公司努力滿足行業標準時，所需的時間和資源可能會限制創新。

個人化醫療的採用日益增多

個人化醫療的重點是根據患者的個人情況提供客製化治療，這對創新細胞培養基產生了巨大的需求。基因組學、蛋白質組學和細胞治療的進步推動了針對特定應用而設計的培養基的需求。 CAR-T細胞療法和其他基於細胞的療法的興起為培養基最佳化創造了更多機會。此外，人們對器官晶片技術和 3D 細胞培養的興趣日益濃厚，拓寬了細胞培養基的應用範圍。個人化醫療是細胞培養基市場的一個活躍成長領域。

技術純熟勞工短缺

對細胞培養技術訓練有素的專業人員的需求通常超過現有的人才庫。人才短缺可能導致產品開發和品管效率低下和延誤。此外，培訓計畫和教育措施不足也加劇了這個問題。缺乏專業知識會使公司難以保持一致性並滿足監管標準。

COVID-19的影響：

COVID-19 疫情加速了對疫苗開發、治療研究和診斷測試的需求，對細胞培養基市場產生了重大影響。人們對生物製藥和 COVID-19 治療的關注度不斷提高，導致細胞培養基在病毒研究和疫苗生產中的使用量激增。然而，供應鏈中斷，包括原料採購延遲和生產瓶頸，暫時阻礙了市場成長。儘管面臨這些挑戰，但這場疫情凸顯了細胞培養基在藥物開發和生物技術中的關鍵作用。

預計合成媒體領域將成為預測期內最大的領域

由於合成培養基具有一致性、可重複性以及精確控制細胞生長條件的能力，預計在預測期內將佔據最大的市場佔有率。確定成分培養基消除了基於血清的配方所帶來的可變性，並提供了更標準化的結果。此外，生物製藥製造、幹細胞研究和細胞療法對無血清、化學成分確定的培養基的偏好日益成長，進一步加速了確定性培養基在各種應用中的應用。

預計腫瘤學研究在預測期內將以最高的複合年成長率成長

由於對有效的癌症治療和早期診斷方法的需求不斷增加，預計癌症研究領域將在預測期內見證最高的成長率。細胞培養基為癌細胞細胞株的培養提供了受控環境，從而實現了藥物發現、腫瘤分析和個人化治療開發。免疫療法和標靶治療的進步，以及人們對癌症生物學日益成長的興趣，進一步推動了對癌症研究中特殊培養基的需求。

佔比最大的地區：

預計亞太地區將在預測期內佔據最大的市場佔有率。這是由於生物技術和製藥行業的擴張、醫療保健投資的增加以及對生物製藥的需求不斷成長。該地區對研發的日益重視，特別是在幹細胞治療、個人化醫療和癌症研究方面，也推動了市場的成長。此外，基礎設施建設和政府加強醫療保健和生物技術領域的措施也促進了亞太地區對細胞培養基的需求不斷增加。

複合年成長率最高的地區：

預計北美地區在預測期內將呈現最高的複合年成長率。這是因為該地區擁有強大的生物技術和製藥產業以及對研發的大量投資。對生技藥品、疫苗和個人化醫療的需求不斷成長，推動了對先進細胞培養基的需求。此外，領先研究機構的存在、對癌症研究和細胞治療的日益關注以及強大的醫療保健基礎設施進一步促進了北美市場的成長。

免費客製化服務

訂閱此報告的客戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 對其他市場公司（最多 3 家公司）進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 地理細分
    • 根據客戶興趣對主要國家市場進行估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

第5章全球細胞培養基市場（依產品類型）

  • 大自然媒體
  • 合成媒體
  • 半合成培養基
  • 無血清培養基
    • CHO媒體
    • HEK 293 培養基
    • BHK中型
    • Velo中型
  • 自訂媒體
  • 傳統媒體
  • 化學成分確定的培養基
  • 其他產品類型

第6章 全球細胞培養基市場（依細胞類型）

  • 哺乳動物細胞
  • 昆蟲細胞
  • 微生物細胞
  • 初代細胞
  • 永生化細胞株

第7章 全球細胞培養基市場（依配方類型）

  • 粉末製劑
  • 液體製劑
  • 集中

第8章全球細胞培養基市場（按應用）

  • 藥物開發與測試
  • 再生醫學
  • 生物製藥製造
  • 癌症研究
  • 幹細胞研究
  • 組織工程
  • 其他用途

第9章全球細胞培養基市場（依最終用戶）

  • 製藥和生物技術
  • 研究和學術機構
  • 合約研究組織（CRO）
  • 醫院和診斷實驗室
  • 其他最終用戶

第 10 章全球細胞培養基市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • Thermo Fisher Scientific, Inc.
  • Bio-Techne Corporation
  • Sigma-Aldrich
  • Merck Millipore
  • Lonza Group
  • Pan-Biotech GmbH
  • GE Healthcare Life Sciences
  • CellGenix GmbH
  • Corning Incorporated
  • Sartorius Stedim Biotech
  • BD Biosciences
  • HiMedia Laboratories
  • Samsung Biologics
  • Miltenyi Biotec
  • Fujifilm Irvine Scientific
Product Code: SMRC28929

According to Stratistics MRC, the Global Cell Culture Media Market is accounted for $6.60 billion in 2025 and is expected to reach $15.25 billion by 2032 growing at a CAGR of 12.7% during the forecast period. Cell culture media are nutrient-rich solutions used to support the growth, maintenance, and propagation of cells in laboratory conditions. They provide essential nutrients, vitamins, amino acids, salts, and growth factors required for cells to thrive outside their natural environment. Culture media can be chemically defined, serum-based, or serum-free, depending on the kind of cell and its intended use. The ability to examine and manipulate cells in vitro makes these media essential in a variety of sectors, such as drug discovery, regenerative medicine, cancer research, and biopharmaceutical production.

According to the WHO, in 2021, there were an estimated 128 000 measles deaths globally, mostly among unvaccinated or under vaccinated children under the age of 5 years.

Market Dynamics:

Driver:

Growing demand for biopharmaceuticals

The rising prevalence of chronic diseases and an aging global population are driving the need for advanced biopharmaceuticals. Biopharmaceuticals require high-quality cell culture media for their production, enhancing the importance of this market. The increasing focus on biologics and biosimilars further propels demand for efficient cell culture media. Moreover, the rise in cell-based research, such as stem cell and regenerative medicine, is accelerating the market's growth. With pharmaceutical companies investing heavily in R&D, the cell culture media market is witnessing steady growth.

Restraint:

Complexity in media development

Developing cell culture media involves intricate formulations tailored to specific cell lines and applications, making it a challenging process. The high costs associated with research, testing, and development of customized media can act as a barrier for small-scale manufacturers. Additionally, stringent regulatory requirements for cell culture products add to the complexity and expenses. Variability in raw materials and inconsistencies in performance create further hurdles for media developers. As companies strive to meet industry standards, the time and resources required can limit innovation.

Opportunity:

Increasing adoption of personalized medicine

Personalized medicine focuses on providing tailored treatments based on individual patient profiles, creating a significant demand for innovative cell culture media. Advances in genomics, proteomics, and cell therapies are driving the need for media designed for specific applications. The rise of CAR-T cell therapies and other cell-based treatments enhances opportunities for media optimization. Additionally, the growing interest in organ-on-chip technologies and 3D cell cultures expands the application of cell culture media. Personalized medicine represents a dynamic growth area for the cell culture media market.

Threat:

Lack of skilled labor

The demand for trained experts in cell culture techniques often outpaces the available talent pool. This talent gap can lead to inefficiencies and delays in product development and quality control. Moreover, insufficient training programs and educational initiatives exacerbate this problem. Companies may face difficulties in maintaining consistency and meeting regulatory standards due to the lack of expertise.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the cell culture media market by accelerating the demand for vaccine development, therapeutic research, and diagnostic tests. The increased focus on biopharmaceuticals and COVID-19 treatments led to a surge in the use of cell culture media for viral research and vaccine production. However, supply chain disruptions, including delays in raw material sourcing and production bottlenecks, temporarily hindered market growth. Despite these challenges, the pandemic highlighted the critical role of cell culture media in drug development and biotechnology.

The synthetic media segment is expected to be the largest during the forecast period

The synthetic media segment is expected to account for the largest market share during the forecast period, due to their consistency, reproducibility, and the ability to precisely control cell growth conditions. Synthetic media eliminate the variability associated with serum-based formulations, offering more standardized results. Additionally, the increasing preference for serum-free and chemically defined media for biopharmaceutical production, stem cell research, and cell-based therapies further accelerates the adoption of synthetic media in various applications.

The cancer research segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cancer research segment is predicted to witness the highest growth rate, due to the increasing need for effective cancer therapies and early diagnostic methods. Cell culture media provide a controlled environment for cultivating cancer cell lines, enabling drug discovery, tumor analysis, and personalized treatment development. Advancements in immunotherapy and targeted therapies, along with the growing focus on understanding cancer biology, further fuel the demand for specialized media in cancer research.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, driven by the expanding biotechnology and pharmaceutical industries, increased healthcare investments, and rising demand for biopharmaceuticals. The region's growing focus on research and development, particularly in stem cell therapies, personalized medicine, and cancer research, also boosts market growth. Additionally, improving infrastructure and government initiatives to enhance healthcare and biotechnology sectors contribute to the rising demand for cell culture media in Asia Pacific.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to the region's robust biotechnology and pharmaceutical industries, coupled with significant investments in research and development. The growing demand for biologics, vaccines, and personalized medicine fuels the need for advanced cell culture media. Additionally, the presence of leading research institutions, increasing focus on cancer research and cell-based therapies, and strong healthcare infrastructure further contribute to market growth in North America.

Key players in the market

Some of the key players in Cell Culture Media Market include Thermo Fisher Scientific, Inc., Bio-Techne Corporation, Sigma-Aldrich, Merck Millipore, Lonza Group, Pan-Biotech GmbH, GE Healthcare Life Sciences, CellGenix GmbH, Corning Incorporated, Sartorius Stedim Biotech, BD Biosciences, HiMedia Laboratories, Samsung Biologics, Miltenyi Biotec, and Fujifilm Irvine Scientific.

Key Developments:

In March 2025, Bio-Techne Corporation announced that Asuragen, a Bio-Techne brand, has teamed up with Oxford Nanopore Technologies to launch the AmplideX(R) Nanopore Carrier plus Kit, a new genetic panel and supporting analysis software for carrier screening research. This innovative kit helps laboratories resolve genes that are challenging to analyze by conventional short-read sequencing and only partially resolved by ancillary assays.

In February 2025, Thermo Fisher Scientific Inc., announced the launch of the CorEvitas Systemic Lupus Erythematosus (SLE) Registry. The multi-center, prospective registry leverages the CorEvitas rheumatology physician network and addresses a critical unmet need for collecting robust, objective real-world data about this chronic and devastating autoimmune disease, in which the immune system attacks healthy tissue and can cause damage to patients' skin, joints, blood and internal organs, including the kidneys, heart, brain and lungs.

Product Types Covered:

  • Natural Media
  • Synthetic Media
  • Semi-synthetic Media
  • Serum-free Media
  • Custom Media
  • Classical Media
  • Chemically Defined Media
  • Other Product Types

Cell Types Covered:

  • Mammalian Cells
  • Insect Cells
  • Microbial Cells
  • Primary Cells
  • Immortalized Cell Lines

Formulation Types Covered:

  • Powder Formulation
  • Liquid Formulation
  • Concentrates

Applications Covered:

  • Drug Development & Testing
  • Regenerative Medicine
  • Biologics Production
  • Cancer Research
  • Stem Cell Research
  • Tissue Engineering
  • Other Applications

End Users Covered:

  • Pharmaceutical and Biotechnology
  • Research and Academic Institutes
  • Contract Research Organizations (CROs)
  • Hospitals and Diagnostic Laboratories
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Cell Culture Media Market, By Product Type

  • 5.1 Introduction
  • 5.2 Natural Media
  • 5.3 Synthetic Media
  • 5.4 Semi-synthetic Media
  • 5.5 Serum-free Media
    • 5.5.1 CHO Media
    • 5.5.2 HEK 293 Media
    • 5.5.3 BHK Medium
    • 5.5.4 Vero Medium
  • 5.6 Custom Media
  • 5.7 Classical Media
  • 5.8 Chemically Defined Media
  • 5.9 Other Product Types

6 Global Cell Culture Media Market, By Cell Type

  • 6.1 Introduction
  • 6.2 Mammalian Cells
  • 6.3 Insect Cells
  • 6.4 Microbial Cells
  • 6.5 Primary Cells
  • 6.6 Immortalized Cell Lines

7 Global Cell Culture Media Market, By Formulation Type

  • 7.1 Introduction
  • 7.2 Powder Formulation
  • 7.3 Liquid Formulation
  • 7.4 Concentrates

8 Global Cell Culture Media Market, By Application

  • 8.1 Introduction
  • 8.2 Drug Development & Testing
  • 8.3 Regenerative Medicine
  • 8.4 Biologics Production
  • 8.5 Cancer Research
  • 8.6 Stem Cell Research
  • 8.7 Tissue Engineering
  • 8.8 Other Applications

9 Global Cell Culture Media Market, By End User

  • 9.1 Introduction
  • 9.2 Pharmaceutical and Biotechnology
  • 9.3 Research and Academic Institutes
  • 9.4 Contract Research Organizations (CROs)
  • 9.5 Hospitals and Diagnostic Laboratories
  • 9.6 Other End Users

10 Global Cell Culture Media Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Thermo Fisher Scientific, Inc.
  • 12.2 Bio-Techne Corporation
  • 12.3 Sigma-Aldrich
  • 12.4 Merck Millipore
  • 12.5 Lonza Group
  • 12.6 Pan-Biotech GmbH
  • 12.7 GE Healthcare Life Sciences
  • 12.8 CellGenix GmbH
  • 12.9 Corning Incorporated
  • 12.10 Sartorius Stedim Biotech
  • 12.11 BD Biosciences
  • 12.12 HiMedia Laboratories
  • 12.13 Samsung Biologics
  • 12.14 Miltenyi Biotec
  • 12.15 Fujifilm Irvine Scientific

List of Tables

  • Table 1 Global Cell Culture Media Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Cell Culture Media Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Cell Culture Media Market Outlook, By Natural Media (2024-2032) ($MN)
  • Table 4 Global Cell Culture Media Market Outlook, By Synthetic Media (2024-2032) ($MN)
  • Table 5 Global Cell Culture Media Market Outlook, By Semi-synthetic Media (2024-2032) ($MN)
  • Table 6 Global Cell Culture Media Market Outlook, By Serum-free Media (2024-2032) ($MN)
  • Table 7 Global Cell Culture Media Market Outlook, By CHO Media (2024-2032) ($MN)
  • Table 8 Global Cell Culture Media Market Outlook, By HEK 293 Media (2024-2032) ($MN)
  • Table 9 Global Cell Culture Media Market Outlook, By BHK Medium (2024-2032) ($MN)
  • Table 10 Global Cell Culture Media Market Outlook, By Vero Medium (2024-2032) ($MN)
  • Table 11 Global Cell Culture Media Market Outlook, By Custom Media (2024-2032) ($MN)
  • Table 12 Global Cell Culture Media Market Outlook, By Classical Media (2024-2032) ($MN)
  • Table 13 Global Cell Culture Media Market Outlook, By Chemically Defined Media (2024-2032) ($MN)
  • Table 14 Global Cell Culture Media Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 15 Global Cell Culture Media Market Outlook, By Cell Type (2024-2032) ($MN)
  • Table 16 Global Cell Culture Media Market Outlook, By Mammalian Cells (2024-2032) ($MN)
  • Table 17 Global Cell Culture Media Market Outlook, By Insect Cells (2024-2032) ($MN)
  • Table 18 Global Cell Culture Media Market Outlook, By Microbial Cells (2024-2032) ($MN)
  • Table 19 Global Cell Culture Media Market Outlook, By Primary Cells (2024-2032) ($MN)
  • Table 20 Global Cell Culture Media Market Outlook, By Immortalized Cell Lines (2024-2032) ($MN)
  • Table 21 Global Cell Culture Media Market Outlook, By Formulation Type (2024-2032) ($MN)
  • Table 22 Global Cell Culture Media Market Outlook, By Powder Formulation (2024-2032) ($MN)
  • Table 23 Global Cell Culture Media Market Outlook, By Liquid Formulation (2024-2032) ($MN)
  • Table 24 Global Cell Culture Media Market Outlook, By Concentrates (2024-2032) ($MN)
  • Table 25 Global Cell Culture Media Market Outlook, By Application (2024-2032) ($MN)
  • Table 26 Global Cell Culture Media Market Outlook, By Drug Development & Testing (2024-2032) ($MN)
  • Table 27 Global Cell Culture Media Market Outlook, By Regenerative Medicine (2024-2032) ($MN)
  • Table 28 Global Cell Culture Media Market Outlook, By Biologics Production (2024-2032) ($MN)
  • Table 29 Global Cell Culture Media Market Outlook, By Cancer Research (2024-2032) ($MN)
  • Table 30 Global Cell Culture Media Market Outlook, By Stem Cell Research (2024-2032) ($MN)
  • Table 31 Global Cell Culture Media Market Outlook, By Tissue Engineering (2024-2032) ($MN)
  • Table 32 Global Cell Culture Media Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 33 Global Cell Culture Media Market Outlook, By End User (2024-2032) ($MN)
  • Table 34 Global Cell Culture Media Market Outlook, By Pharmaceutical and Biotechnology (2024-2032) ($MN)
  • Table 35 Global Cell Culture Media Market Outlook, By Research and Academic Institutes (2024-2032) ($MN)
  • Table 36 Global Cell Culture Media Market Outlook, By Contract Research Organizations (CROs) (2024-2032) ($MN)
  • Table 37 Global Cell Culture Media Market Outlook, By Hospitals and Diagnostic Laboratories (2024-2032) ($MN)
  • Table 38 Global Cell Culture Media Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.